A detailed history of Global Retirement Partners, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 104 shares of NTLA stock, worth $1,739. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104
Previous 104 -0.0%
Holding current value
$1,739
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$20.02 - $27.22 $820 - $1,116
41 Added 65.08%
104 $2,000
Q1 2024

Apr 23, 2024

SELL
$23.82 - $32.8 $95 - $131
-4 Reduced 5.97%
63 $1,000
Q4 2023

Jan 18, 2024

BUY
$23.16 - $32.34 $23 - $32
1 Added 1.52%
67 $2,000
Q3 2023

Oct 13, 2023

SELL
$31.62 - $45.78 $126 - $183
-4 Reduced 5.71%
66 $2,000
Q1 2023

May 05, 2023

BUY
$33.3 - $44.82 $233 - $313
7 Added 11.11%
70 $2,000
Q1 2022

Jul 14, 2022

BUY
$58.27 - $118.99 $3,671 - $7,496
63 New
63 $3,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.27B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.